Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy—Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.5883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von H M Gunter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town,…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Antitubercular Agents, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Academy of Medical Sciences, United Kingdom, Academy of Medical Sciences.
Abstract (Originalsprache)
Purpose
We compared performance of the Roussel Uclaf Causality Assessment Method (RUCAM) with multidisciplinary expert panel review in identifying a drug‐induced liver injury (DILI) due to antituberculosis therapy (ATT) and/or antiretroviral therapy (ART).
Methods
Cases were drawn from a prospective registry of hospitalised adults with suspected DILI due to ATT and/or ART in Cape Town, South Africa. Participants had to fulfil American Thoracic Society criteria for ATT interruption (alanine transaminase [ALT] ≥5 times upper limit of normal [ULN]/ALT ≥3 times [ULN] and symptomatic). Causality assessment by expert panel review served as reference standard. The panel ranked potentially implicated drugs as certain, probable, possible or unlikely causes guided by World Health Organization Uppsala Monitoring Centre criteria. The RUCAM was performed for each potentially implicated drug. We calculated sensitivity and specificity of the RUCAM in identifying a probable/certain drug cause for liver injury.
Results
We included 48 participants. All were people with HIV (PWH). Twenty‐seven were on concomitant ART and ATT, with a median of six potentially hepatotoxic drugs per case. Sensitivity and specificity of the RUCAM in identifying a probable/certain drug cause of liver injury compared with expert panel review was 7% and 100% respectively. Implicated drugs (times ranked probable/certain by panel) were isoniazid (18/0), pyrazinamide (17/0), rifampicin (15/1), efavirenz (6/4) and lopinavir/ritonavir (1/0).
Conclusions
PWH with liver injury received multiple potentially implicated drugs, which may increase liver injury risk and complicate causality assessment. Compared with expert panel review, the RUCAM had low sensitivity in detecting probable or certain drug causes of liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
- Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
- Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.
ORCID-Profile: K Cohen
Förderung
- Academy of Medical Sciences, United Kingdom
- Academy of Medical Sciences
Zitieren
APA
Gunter, H. M., Tatz, G., Maartens, G., Spearman, C. W., Mehta, U., & Cohen, K. (2024). Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy—Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5883
Vancouver
Gunter HM, Tatz G, Maartens G, Spearman CW, Mehta U, Cohen K. Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy—Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5883
BibTeX
@article{Gunter2024,
author = {Gunter, H M and Tatz, G and Maartens, G and Spearman, C W and Mehta, U and Cohen, K},
title = {Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy—Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.5883}
}
EUVIMED